The global tinea pedis treatment market size accounted for USD 1,498 million in 2024 and is predicted to touch around USD 2,511 million by 2034, growing at a CAGR of 5.3% from 2024 to 2034.
Tinea pedis also known as athlete’s foot is a fungal infection that is localized on the skin of the foot. It is a highly infective disease caused by various types of fungi, Trichophyton, Epidermophyton, and Microsporum. Tinea pedis is usually treated using antifungal solutions. These can be bought without a prescription in the form of creams, ointments, or even sprays that contain ingredients such as terbinafine, clotrimazole, or miconazole.
The tinea pedis treatment market is growing due to the rising incidence of fungal foot infection across the world, changing lifestyles, growing awareness regarding the need for early treatment, the elderly population at higher risk of fungal infections, and advancement in treatment methods. The growing incidence of regulatory approvals along with the higher availability of over-the-counter drugs for fungal infections is also favoring the tinea pedis treatment market.
The North American market held the largest market share. Tinea pedis is more common in the region than in other parts of the world due to environmental factors of lifestyles such as the widespread use of communal facilities like gyms and swimming pools.
Published by Laxmi Narayan
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
| Stats ID: | 7338 |
| Format: | Databook |
| Published: | January 2025 |
| Delivery: | Immediate |
| Price | US$ 1550 |
| Stats ID: | 7338 |
| Format: | Databook |
| Published: | January 2025 |
| Delivery: | Immediate |
| Price | US$ 1550 |
Unlock unlimited access to all exclusive market research reports, empowering your business.
Get industry insights at the most affordable plan
Stay ahead of the competition with comprehensive, actionable intelligence at your fingertips!
Learn More
Download
Order Databook
Actionable Solutions
